USA TodayMy son needs insulin to survive. Plans to lower drug costs are welcome, but not enough.
- Bias Rating
-10% Center
- Reliability
N/AN/A
- Policy Leaning
-4% Center
- Politician Portrayal
6% Positive
Continue For Free
Create your free account to see the in-depth bias analytics and more.
Continue
Continue
By creating an account, you agree to our Terms and Privacy Policy, and subscribe to email updates. Already a member: Log inBias Score Analysis
The A.I. bias rating includes policy and politician portrayal leanings based on the author’s tone found in the article using machine learning. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral.
Sentiments
N/A
- Liberal
- Conservative
| Sentence | Sentiment | Bias |
|---|---|---|
Unlock this feature by upgrading to the Pro plan. | ||
Reliability Score Analysis
Policy Leaning Analysis
Politician Portrayal Analysis
Bias Meter
Extremely
Liberal
Very
Liberal
Moderately
Liberal
Somewhat Liberal
Center
Somewhat Conservative
Moderately
Conservative
Very
Conservative
Extremely
Conservative
-100%
Liberal
100%
Conservative
Contributing sentiments towards policy:
55% : The overall cost for individuals, even with private health insurance, is on average almost $10,000 a year.48% : Here's why blocking it isn't a good idea However, even with private insurance, high-deductible plans require patients to pay for 100% of the costs until their deductible is met.
44% : While the newly passed Inflation Reduction Act caps monthly insulin costs for Medicare patients at $35 a month, it does not cover the broader patient population under private health insurance.
*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.